CytomX Therapeutics, Inc. (CTMX)
2.905
-0.08
(-2.52%)
USD |
NASDAQ |
Jun 10, 16:00
2.895
-0.01
(-0.34%)
After-Hours: 20:00
CytomX Therapeutics EPS Diluted (TTM) : -0.3637 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.3637 |
| December 31, 2025 | 0.0091 |
| September 30, 2025 | 0.4182 |
| June 30, 2025 | 0.5717 |
| March 31, 2025 | 0.4959 |
| December 31, 2024 | 0.3929 |
| September 30, 2024 | 0.1696 |
| June 30, 2024 | 0.1392 |
| March 31, 2024 | 0.1999 |
| December 31, 2023 | -0.017 |
| September 30, 2023 | -0.1619 |
| June 30, 2023 | -0.6398 |
| March 31, 2023 | -0.9925 |
| December 31, 2022 | -1.432 |
| September 30, 2022 | -1.700 |
| June 30, 2022 | -1.605 |
| March 31, 2022 | -1.532 |
| December 31, 2021 | -1.298 |
| September 30, 2021 | -1.214 |
| June 30, 2021 | -1.187 |
| March 31, 2021 | -1.231 |
| December 31, 2020 | -0.7167 |
| September 30, 2020 | -1.179 |
| Date | Value |
|---|---|
| June 30, 2020 | -1.383 |
| March 31, 2020 | -1.681 |
| December 31, 2019 | -2.254 |
| September 30, 2019 | -2.188 |
| June 30, 2019 | -2.200 |
| March 31, 2019 | -1.912 |
| December 31, 2018 | -1.998 |
| September 30, 2018 | -1.267 |
| June 30, 2018 | -1.011 |
| March 31, 2018 | -1.351 |
| December 31, 2017 | -1.181 |
| September 30, 2017 | -1.582 |
| June 30, 2017 | -1.705 |
| March 31, 2017 | -1.405 |
| December 31, 2016 | -1.615 |
| September 30, 2016 | -1.564 |
| June 30, 2016 | -15.42 |
| March 31, 2016 | -15.15 |
| December 31, 2015 | -14.93 |
| September 30, 2015 | -14.59 |
| June 30, 2015 | -0.3328 |
| March 31, 2015 | -0.2128 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 41.04 |
| Ocugen, Inc. | -0.2318 |
| Catalyst Pharmaceuticals, Inc. | 1.740 |
| Rigel Pharmaceuticals, Inc. | 18.72 |
| iBio, Inc. | -0.5777 |